Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions

<p>Abstract</p> <p>Background</p> <p>The current paradigm for cord blood transplantation is that HLA matching and immune suppression are strictly required to prevent graft versus host disease (GVHD). Immunological arguments and historical examples have been made that th...

Full description

Bibliographic Details
Main Authors: Luo Xiao-Ling, Zhang Min, Minev Boris, Min Wei-Ping, Wu Fang, Zhang Yun, Yang Wan-Zhang, Ramos Famela, Ichim Thomas E, Riordan Neil H, Hu Xiang
Format: Article
Language:English
Published: BMC 2010-08-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/8/1/75

Internet

http://www.translational-medicine.com/content/8/1/75

Similar Items